CLA250 APO
Pill imprint CLA250 APO has been identified as Clarithromycin 250 mg.
Clarithromycin is used in the treatment of dental abscess; upper respiratory tract infection; strep throat; sinusitis; bronchitis (and more), and belongs to the drug class macrolides. Risk cannot be ruled out during pregnancy.
Clarithromycin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Clarithromycin Images
- Imprint:
-
CLA250
APO - Strength:
- 250 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Macrolides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2616
Advertisement
More Clarithromycin resources
- Clarithromycin
- Clarithromycin (Wolters Kluwer)
- Clarithromycin Extended-Release Tablets (Wolters Kluwer)
- Clarithromycin Suspension (Wolters Kluwer)
- clarithromycin (Cerner Multum)
- clarithromycin (Micromedex) - Includes Dosage Information
- Clarithromycin (AHFS DI)
- Clarithromycin (FDA)
- Clarithromycin ER (FDA)
- Clarithromycin Suspension (FDA)
- Clarithromycin (Wolters Kluwer)
Clarithromycin is associated with the treatment of:
- Bacterial Endocarditis Prevention
- Bronchitis
- Dental Abscess
- Helicobacter Pylori Infection
- Legionella Pneumonia
- Mycobacterium avium-intracellulare, Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Otitis Media
- Pertussis
- Pharyngitis
- Pneumonia
- Sinusitis
- Skin and Structure Infection
- Skin Infection
- Strep Throat
- Toxoplasmosis
- Upper Respiratory Tract Infection
Search Again
